Bladder cancer radiation trial halted early – only 2 patients enrolled
NCT ID NCT05700227
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new type of radiation therapy that adapts daily to the patient's anatomy, combined with chemotherapy, for muscle-invasive bladder cancer. The goal was to see if this approach could lower severe bowel and bladder side effects compared to standard radiation. However, the trial was terminated early after enrolling only 2 participants, so no conclusions can be drawn.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University, St. Louis
St Louis, Missouri, 63110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could detect bladder Cancer's return — a trial puts it to the test
- New combination aims to save bladders in Muscle-Invasive cancer
- Needle-Sized device could reveal which bladder cancer drug works best
- Could fewer radiation sessions be just as effective for bladder cancer?
- Gene therapy joins forces with chemo and immunotherapy to fight bladder cancer
- New hope for bladder cancer patients who can't have standard chemo